Literature DB >> 30362548

Mitochondrial dysfunction and inhibition of myoblast differentiation in mice with high-fat-diet-induced pre-diabetes.

Dengqiu Xu1, Zhenzhou Jiang1,2, Zeren Sun1, Lu Wang1, Guolin Zhao1, Hozeifa M Hassan1, Sisi Fan1, Wang Zhou1, Shuangshuang Han1, Luyong Zhang1,2,3, Tao Wang1,4.   

Abstract

Pre-diabetes is characterized by impaired glucose tolerance (IGT) and/or impaired fasting glucose. Impairment of skeletal muscle function is closely associated with the progression of diabetes. However, the entire pathological characteristics and mechanisms of pre-diabetes in skeletal muscle remain fully unknown. Here, we established a mouse model of pre-diabetes, in which 6-week-old male C57BL6/J mice were fed either normal diet or high-fat diet (HFD) for 8 or 16 weeks. Both non-fasting and fasting glucose levels and the results of glucose and insulin tolerance tests showed that mice fed an 8-week HFD developed pre-diabetes with IGT; whereas mice fed a 16-week HFD presented with impaired fasting glucose and impaired glucose tolerance (IFG-IGT). Mice at both stages of pre-diabetes displayed decreased numbers of mitochondria in skeletal muscle. Moreover, IFG-IGT mice exhibited decreased mitochondrial membrane potential and ATP production in skeletal muscle and muscle degeneration characterized by a shift in muscle fibers from predominantly oxidative type I to glycolytic type II. Western blotting and histological analysis confirmed that myoblast differentiation was only inhibited in IFG-IGT mice. For primary skeletal muscle satellite cells, inhibition of differentiation was observed in palmitic acid-induced insulin resistance model. Moreover, enhanced myoblast differentiation increased glucose uptake and insulin sensitivity. These findings indicate that pre-diabetes result in mitochondrial dysfunction and inhibition of myoblast differentiation in skeletal muscle. Therefore, interventions that enhance myoblast differentiation may improve insulin resistance of diabetes at the earlier stage.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  high-fat diet (HFD); mitochondria; myoblast differentiation; pre-diabetes

Mesh:

Substances:

Year:  2018        PMID: 30362548     DOI: 10.1002/jcp.27512

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

1.  Sex differences in cardio-metabolic and cognitive parameters in rats with high-fat diet-induced metabolic dysfunction.

Authors:  You Kyoung Shin; Yu Shan Hsieh; A Young Han; Soonho Kwon; Geun Hee Seol
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-16

2.  Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway.

Authors:  Yujie Huang; Xiaohui Zhu; Ka Chen; Hedong Lang; Yong Zhang; Pengfei Hou; Li Ran; Min Zhou; Jiawei Zheng; Long Yi; Mantian Mi; Qianyong Zhang
Journal:  Aging (Albany NY)       Date:  2019-04-15       Impact factor: 5.682

3.  Multi-Tissue DNA Methylation Remodeling at Mitochondrial Quality Control Genes According to Diet in Rat Aging Models.

Authors:  Patrizia D'Aquila; Francesco De Rango; Francesco Guarasci; Maurizio Mandalà; Andrea Corsonello; Dina Bellizzi; Giuseppe Passarino
Journal:  Nutrients       Date:  2020-02-12       Impact factor: 5.717

4.  The hypoglycemic mechanism of catalpol involves increased AMPK-mediated mitochondrial biogenesis.

Authors:  Deng-Qiu Xu; Chun-Jie Li; Zhen-Zhou Jiang; Lu Wang; Hong-Fei Huang; Zhi-Jian Li; Li-Xin Sun; Si-Si Fan; Lu-Yong Zhang; Tao Wang
Journal:  Acta Pharmacol Sin       Date:  2020-01-14       Impact factor: 6.150

5.  TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy.

Authors:  Dengqiu Xu; Sijia Li; Lu Wang; Jingwei Jiang; Lei Zhao; Xiaofei Huang; Zeren Sun; Chunjie Li; Lixin Sun; Xihua Li; Zhenzhou Jiang; Luyong Zhang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-11-25       Impact factor: 12.910

Review 6.  Disease-associated metabolic alterations that impact satellite cells and muscle regeneration: perspectives and therapeutic outlook.

Authors:  Josiane Joseph; Jason D Doles
Journal:  Nutr Metab (Lond)       Date:  2021-03-25       Impact factor: 4.169

7.  20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy in vitro.

Authors:  Manying Wang; Rui Jiang; Jianzeng Liu; Xiaohao Xu; Guang Sun; Daqing Zhao; Liwei Sun
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

8.  MiR-96-5p Induced by Palmitic Acid Suppresses the Myogenic Differentiation of C2C12 Myoblasts by Targeting FHL1.

Authors:  Mai Thi Nguyen; Kyung-Ho Min; Wan Lee
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

9.  Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway.

Authors:  Deng-Qiu Xu; Lei Zhao; Si-Jia Li; Xiao-Fei Huang; Chun-Jie Li; Li-Xin Sun; Xi-Hua Li; Lu-Yong Zhang; Zhen-Zhou Jiang
Journal:  Acta Pharmacol Sin       Date:  2020-09-16       Impact factor: 7.169

10.  A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1.

Authors:  Dengqiu Xu; Lei Zhao; Jingwei Jiang; Sijia Li; Zeren Sun; Xiaofei Huang; Chunjie Li; Tao Wang; Lixin Sun; Xihua Li; Zhenzhou Jiang; Luyong Zhang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-08-31       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.